Dublin, April 12, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering.
This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine
The report provides current share of each segment: market size in 2015 and projected value for the years 2020 and 2025. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.
Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. Biochip and Microarray Technologies
3. Microfluidics-based Biochips and Microarrays
4. Protein Biochips
5. Nanobiotechnology-based Biochips & Microarrays
6. Biochips & Microarrays for Epigenetics
7. Applications of Microarrays in Drug Discovery & Development
8. Biochips for Biomarkers, Molecular Diagnostics & Personalized
9. Markets
10. Companies
11. References
For more information visit http://www.researchandmarkets.com/research/tr7kdd/biochips_and
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Volkswagen Q1 2026 Sales Decline Amid China and U.S. Market Pressures
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 



